154 related articles for article (PubMed ID: 22286585)
1. Personalized therapy in breast cancer.
Marmé F; Schneeweiss A
Onkologie; 2012; 35 Suppl 1():28-33. PubMed ID: 22286585
[TBL] [Abstract][Full Text] [Related]
2. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
3. Recent developments and future perspectives of personalized oncology.
Grüllich C; von Kalle C
Onkologie; 2012; 35 Suppl 1():4-7. PubMed ID: 22286581
[TBL] [Abstract][Full Text] [Related]
4. Personalized medicine: the road ahead.
Mehta R; Jain RK; Badve S
Clin Breast Cancer; 2011 Mar; 11(1):20-6. PubMed ID: 21421518
[TBL] [Abstract][Full Text] [Related]
5. [Effective treatment strategy in elderly breast cancer patients].
Boér K
Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
[TBL] [Abstract][Full Text] [Related]
6. [Clinical trials and personalized medicine in oncology?].
Arnold D; Bokemeyer C
Onkologie; 2010; 33 Suppl 7():25-9. PubMed ID: 20926911
[TBL] [Abstract][Full Text] [Related]
7. Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.
Masood S
Surg Oncol Clin N Am; 1995 Oct; 4(4):601-32. PubMed ID: 8535901
[TBL] [Abstract][Full Text] [Related]
8. Personalized treatment of colorectal cancer.
Arnold D; Stein A
Onkologie; 2012; 35 Suppl 1():42-8. PubMed ID: 22286587
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer and neoadjuvant therapy: any predictive marker?
Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
12. Triple-negative breast cancer.
Stockmans G; Deraedt K; Wildiers H; Moerman P; Paridaens R
Curr Opin Oncol; 2008 Nov; 20(6):614-20. PubMed ID: 18841042
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles as an additional tool to conventional predictive factors to assist in management of early endocrine responsive breast cancer.
Chow LW
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S13-7. PubMed ID: 20374025
[TBL] [Abstract][Full Text] [Related]
14. Personalized treatment of early-stage breast cancer: present concepts and future directions.
Harbeck N; Salem M; Nitz U; Gluz O; Liedtke C
Cancer Treat Rev; 2010 Dec; 36(8):584-94. PubMed ID: 20554119
[TBL] [Abstract][Full Text] [Related]
15. Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.
Hanrahan EO; Valero V; Gonzalez-Angulo AM; Hortobagyi GN
J Clin Oncol; 2006 May; 24(13):2113-22. PubMed ID: 16648513
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in breast cancer.
Merkel DE; Osborne CK
Hematol Oncol Clin North Am; 1989 Dec; 3(4):641-52. PubMed ID: 2558104
[TBL] [Abstract][Full Text] [Related]
17. Treatment of metastatic breast cancer: present and future prospects.
Hayes DF; Henderson IC; Shapiro CL
Semin Oncol; 1995 Apr; 22(2 Suppl 5):5-19; discussion 19-21. PubMed ID: 7537913
[TBL] [Abstract][Full Text] [Related]
18. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
19. p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer.
Yamashita H; Toyama T; Nishio M; Ando Y; Hamaguchi M; Zhang Z; Kobayashi S; Fujii Y; Iwase H
Breast Cancer Res; 2006; 8(4):R48. PubMed ID: 16869955
[TBL] [Abstract][Full Text] [Related]
20. Individualized targeted therapy for glioblastoma: fact or fiction?
Weller M; Stupp R; Hegi M; Wick W
Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
